image: BioResearch Open Access is published online six times per year. For more information visit www.liebertpub.com/biores. view more
Credit: ©2013 Mary Ann Liebert, Inc., publishers
New Rochelle, NY, April 9, 2013—One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types. A series of experiments that demonstrate the successful use of fat cells as part of a feeder layer to support prolonged growth of hHSCs in culture is reported in an article in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers. The article is available on the BioResearch Open Access website.
In the article "Extending Human Hematopoietic Stem Cell Survival In Vitro with Adipocytes" Dean Liang Glettig and David Kaplan, Tufts University, Medford, MA included adipocytes (fat cells) in varying amounts and locations in the feeder layers of hHSCs being grown in the laboratory. They varied the concentrations of different cell types including adipocytes in the feeder layer, comparing different amounts of adipocytes, and evaluated the effect of direct cell-to-cell contact between the hHSCs and the adipocytes in the feeder layer on the survival rate of the hHSCs.
"The ability to prolong hHSC culture in vitro not only benefits basic stem cell research, it is also an important step towards developing advanced cell therapies for future clinical use," says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland.
About the Journal
BioResearch Open Access is a bimonthly peer-reviewed open access journal led by Editor-in-Chief Robert Lanza, MD, Chief Scientific Officer, Advanced Cell Technology, Inc. and Editor Jane Taylor, PhD. The Journal provides a new rapid-publication forum for a broad range of scientific topics including molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience. All articles are published within 4 weeks of acceptance and are fully open access and posted on PubMed Central. All journal content is available on the BioResearch Open Access website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Tissue Engineering, Stem Cells and Development, Human Gene Therapy and HGT Methods, and AIDS Research and Human Retroviruses. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website (https://www.liebertpub.com).
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 http://www.liebertpub.com Phone: 914-740-2100 800-M-LIEBERT Fax: 914-740-2101
Journal
BioResearch Open Access